Enhancement in dissolution pattern of piribedil by molecular encapsulation with β-cyclodextrin

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 28, Issue 2, 2006, Pages 83-88

  Demirel, Müzeyyen ^a   Buyukkoroglu G ^a   Kalava, B S ^a   Yazan, Y ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

cyclodextrin; Molecular encapsulation; Piribedil

Indexed keywords

BETA CYCLODEXTRIN; PIRIBEDIL;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG ABSORPTION; DRUG MIXTURE; DRUG SYNTHESIS; ENCAPSULATION; GRINDING; PARTICLE SIZE; SOLID STATE; SPRAY DRYING; THERMOGRAPHY; ULTRAVIOLET SPECTROPHOTOMETRY; VALIDATION STUDY; X RAY DIFFRACTION;

ANTIPARKINSON AGENTS; BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; PARTICLE SIZE; PIRIBEDIL; SOLUBILITY; X-RAY DIFFRACTION;

EID: 33646269704     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2006.28.2.977838     Document Type: Article

References (21)

1. Issa, Y.M., Hassouna, M.M., Abdel-Gawad, F.M., Hussein, E.M. Poly(vinyl chloride) ion-selective electrodes for Piribedil determination. J Pharm Biomed Anal 2000, 23: 493-502.
2. Tsai, R.S., El Tayar, N., Carrupt, P.A., Testa, B. Physicochemical properties and transport behaviour of piribedil: Considerations on its membrane-crossing potential. Int J Pharm Sci 1992, 80: 39-49.
3. Legendre, J.Y., Rault, I., Petit, A. et al. Effects of beta-cyclodextrins on skin: Implications for the transdermal delivery of piribedil and a novel cognition enhancing-drug, S-9977. Eur J Pharm Sci 1995, 3: 311-22.
4. Loftsson, T. Pharmaceutical applications of beta-cyclodextrin. Pharm Technol 1999, 9: 40-50.
5. Duchene, D., Wouessidjewe, D. Physicochemical characteristics and pharmaceutical uses of cyclodextrin derivatives 1. Pharm Technol 1990, 14: 26-9.
6. Fernandes, C.M., Vieira, M.T., Veiga, F.J.B. Physicochemical characterization and in vitro dissolution behavior of nicardipin-cyclodextrins inclusion compounds. Eur J Pharm Sci 2002, 15: 79-88.
7. Barbiric, D.J., Castro, E.A., de Rossi, R.H. A molecular mechanics study of 1:1 complexes between azobenzene derivatives and beta-cyclodextrin. J Molec Struc (Theochem) 2000, 532: 171-81.
8. Ruan, L.P., Yu, B.Y., Fu, G.M., Zhu, D. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J Pharm Biomed Anal 2005, 38(3): 457-64.
9. Li, N., Zhang, Y.H., Xiong, X.L., Li, Z.G., Jin, X.H., Wu, Y.N. Study of the physicochemical properties of trimethoprim with beta-cyclodextrin in solution. J Pharm Biomed Anal 2005, 38(2): 370-4.
10. Venugopal, K., Saha, R.N. New, simple and validated UV-spectrophotometric methods for the estimation of gatifloxacin in bulk and formulations. Farmaco, in press.
11. Higuchi, T., Connors, K.A. Phase-solubility techniques. Adv Anal Chem Instrum 1965, 4: 117-210.
12. USP 24-NF 19. National Publishing: Philadelphia 2000, 1942.
13. Van Hees, T., Piel, G., de Hassonville, S.H., Evrard, B., Delattre, L. Determination of the free/included piroxicam ratio in cyclodextrin complexes: Comparison between UV spectrophotometry and differential scanning calorimetry. Eur J Pharm Sci 2002, 15: 347-53.
14. Lin, S.Y., Kao, Y.H. Solid particulates of drug-beta-cyclodextrin inclusion complexes directly prepared by a spray-drying technique. Int J Pharm 1989, 56: 249-59.
15. Cabral Marques, H., Hadgraft, J., Kellaway, I.W. Studies of cyclodextrin inclusion complexes I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC. Int J Pharm 1990, 63: 259-66.
16. Ginés, J.M., Pérez-Martínez, J.I., Arias, M.J. Inclusion of the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) with beta-cyclodextrin by different processing methods. Chemosphere 1996, 33(2): 321-34.
17. Riberio, L.S.S., Ferreira, D.C., Veiga, F.J.B. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with beta-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. Eur J Pharm Sci 2003, 20: 253-66.
18. Wulff, M., Aldén, M. Solid state studies of drug-cyclodextrin inclusion complexes in PEG 6000 prepared by a new method. Eur J Pharm Sci 1999, 8: 269-81.
19. 1H NMR and ROESY experiments. Eur J Pharm Sci 2003, 18: 285-96.
20. Riberio, L., Carvalho, R.A., Ferreira, D.C., Veiga, F.J.B. Multi-component complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies. Eur J Pharm Sci 2005, 24: 1-13.
21. Smith, J.S., MacRae, R.J., Snowden, M.J. Effect of SBE7-beta-cyclodextrin complexation on carbamazepine release from sustained release beads. Eur J Pharm Biopharm 2005, 60: 73-80.